Company’s 36-month beta value is 1.93.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for STSS is 1.02M, and currently, short sellers hold a 11.45% ratio of that floaft. The average trading volume of STSS on June 18, 2025 was 1.47M shares.
STSS) stock’s latest price update
Sharps Technology Inc (NASDAQ: STSS)’s stock price has gone rise by 13.37 in comparison to its previous close of 5.01, however, the company has experienced a -5.80% decrease in its stock price over the last five trading days. globenewswire.com reported 2025-06-18 that Second commercial delivery underway as part of multi-year contract with leading U.S. healthcare partner Strategic manufacturing upgrades drive scalability, efficiency, and increases capacity to support production growth NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced an update on the execution of its first shipments under the previously announced $50 million SoloGard sales agreement, alongside a series of advanced manufacturing upgrades. Sharps has initiated the second shipment of its first commercial order of SoloGard syringes under a multi-year supply agreement with a U.S.-based leader in IV flushing solutions.
STSS’s Market Performance
STSS’s stock has fallen by -5.80% in the past week, with a monthly rise of 32.71% and a quarterly drop of -94.05%. The volatility ratio for the week is 3.29% while the volatility levels for the last 30 days are 12.83% for Sharps Technology Inc The simple moving average for the past 20 days is 16.20% for STSS’s stock, with a -98.85% simple moving average for the past 200 days.
STSS Trading at 0.92% from the 50-Day Moving Average
After a stumble in the market that brought STSS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.75% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STSS starting from Hayes Robert Michael, who purchase 175,000 shares at the price of $0.04 back on Feb 28 ’25. After this action, Hayes Robert Michael now owns 275,882 shares of Sharps Technology Inc, valued at $7,000 using the latest closing price.
Hayes Robert Michael, the Chief Executive Officer of Sharps Technology Inc, purchase 125,000 shares at $0.03 during a trade that took place back on Mar 31 ’25, which means that Hayes Robert Michael is holding 400,882 shares at $3,750 based on the most recent closing price.
Stock Fundamentals for STSS
The total capital return value is set at -0.76. Equity return is now at value -75.14, with -44.46 for asset returns.
Currently, EBITDA for the company is -9.63 million with net debt to EBITDA at 1.65. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.65.
Conclusion
In a nutshell, Sharps Technology Inc (STSS) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
